Davita Stock Price, News & Analysis (NYSE:DVA)

$73.18 +1.11 (+1.54 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$73.18
Today's Range$71.70 - $73.36
52-Week Range$52.51 - $80.71
Volume1.06 million shs
Average Volume1.46 million shs
Market Capitalization$13.15 billion
P/E Ratio21.27
Dividend YieldN/A
Beta0.99

About Davita (NYSE:DVA)

Davita logoDaVita Inc., formerly DaVita HealthCare Partners Inc., operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. Its DMG division is a patient- and physician-focused integrated healthcare delivery and management company that provides medical services to members through capitation contracts. Its segments include U.S. dialysis and related lab services, DMG, and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2016, it had operated or provided administrative services to 154 outpatient dialysis centers.

Receive DVA News and Ratings via Email

Sign-up to receive the latest news and ratings for DVA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Healthcare Facilities & Services
Sub-IndustryHealth Care Services
SectorMedical
SymbolNYSE:DVA
CUSIP23918K10
Phone303-405-2100

Debt

Debt-to-Equity Ratio1.87%
Current Ratio2.88%
Quick Ratio2.82%

Price-To-Earnings

Trailing P/E Ratio21.2732558139535
Forward P/E Ratio17.51
P/E Growth1.55

Sales & Book Value

Annual Sales$10.88 billion
Price / Sales1.23
Cash Flow$7.83 per share
Price / Cash9.35
Book Value$26.78 per share
Price / Book2.73

Profitability

Trailing EPS$3.44
Net Income$663.61 million
Net Margins4.65%
Return on Equity12.86%
Return on Assets3.43%

Miscellaneous

Employees70,300
Outstanding Shares182,460,000

Davita (NYSE:DVA) Frequently Asked Questions

What is Davita's stock symbol?

Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

How will Davita's stock buyback program work?

Davita announced that its Board of Directors has approved a stock buyback plan on Wednesday, October 11th 2017, which permits the company to repurchase $1,500,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are generally an indication that the company's board of directors believes its stock is undervalued.

How were Davita's earnings last quarter?

Davita Inc (NYSE:DVA) announced its earnings results on Tuesday, February, 13th. The company reported $0.92 EPS for the quarter, missing analysts' consensus estimates of $0.94 by $0.02. The business earned $2.78 billion during the quarter, compared to analyst estimates of $3.90 billion. Davita had a return on equity of 12.86% and a net margin of 4.65%. During the same period in the previous year, the business posted $0.98 earnings per share. View Davita's Earnings History.

When will Davita make its next earnings announcement?

Davita is scheduled to release their next quarterly earnings announcement on Tuesday, May, 1st 2018. View Earnings Estimates for Davita.

Where is Davita's stock going? Where will Davita's stock price be in 2018?

11 equities research analysts have issued 12-month price targets for Davita's stock. Their forecasts range from $60.00 to $97.00. On average, they expect Davita's share price to reach $79.00 in the next twelve months. View Analyst Ratings for Davita.

Who are some of Davita's key competitors?

Who are Davita's key executives?

Davita's management team includes the folowing people:

  • Kent J. Thiry, Chairman of the Board (Age 61)
  • James K. Hilger, Interim Chief Financial Officer, Chief Accounting Officer (Age 55)
  • Joel Ackerman, Chief Financial Officer (Age 51)
  • Robert Lang, President, International Business
  • Javier J. Rodriguez, Chief Executive Officer - Kidney Care (Age 46)
  • Jeanine M. Jiganti, Chief Compliance Officer (Age 57)
  • LeAnne M. Zumwalt, Group Vice President - purchasing and government affairs (Age 58)
  • Kathleen Alyce Waters, Chief Legal Officer (Age 49)
  • Peter T. Grauer, Lead Director, Independent Director (Age 71)
  • Pamela M. Arway, Independent Director (Age 63)

Who owns Davita stock?

Davita's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.85%), Bank of New York Mellon Corp (1.78%), Millennium Management LLC (1.10%), Gates Capital Management Inc. (1.05%), OppenheimerFunds Inc. (1.02%) and Park West Asset Management LLC (0.90%). Company insiders that own Davita stock include Charles Berg, Dennis Kogod, James K Hilger, Javier Rodriguez, Jeanine Marie Jiganti, John M Nehra, Kent J Thiry, Leanne M Zumwalt, Michael David Staffieri, Pamela M Arway, Roger Valine and William L Roper. View Institutional Ownership Trends for Davita.

Who sold Davita stock? Who is selling Davita stock?

Davita's stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, APG Asset Management N.V., TimesSquare Capital Management LLC, Robeco Institutional Asset Management B.V., Gates Capital Management Inc., Park West Asset Management LLC, Bank of Montreal Can and PGGM Investments. Company insiders that have sold Davita company stock in the last year include Charles Berg, James K Hilger, Javier Rodriguez, Kent J Thiry, Leanne M Zumwalt and William L Roper. View Insider Buying and Selling for Davita.

Who bought Davita stock? Who is buying Davita stock?

Davita's stock was purchased by a variety of institutional investors in the last quarter, including OppenheimerFunds Inc., Millennium Management LLC, Bridger Management LLC, International Value Advisers LLC, Locust Wood Capital Advisers LLC, Deutsche Bank AG, Tavio Capital LLC and Allianz Asset Management GmbH. View Insider Buying and Selling for Davita.

How do I buy Davita stock?

Shares of Davita can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Davita's stock price today?

One share of Davita stock can currently be purchased for approximately $73.18.

How big of a company is Davita?

Davita has a market capitalization of $13.15 billion and generates $10.88 billion in revenue each year. The company earns $663.61 million in net income (profit) each year or $3.44 on an earnings per share basis. Davita employs 70,300 workers across the globe.

How can I contact Davita?

Davita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 303-405-2100 or via email at [email protected]


MarketBeat Community Rating for Davita (DVA)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  328 (Vote Outperform)
Underperform Votes:  341 (Vote Underperform)
Total Votes:  669
MarketBeat's community ratings are surveys of what our community members think about Davita and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Davita (NYSE:DVA) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyHoldHold
Consensus Rating Score: 2.642.641.892.11
Ratings Breakdown: 1 Sell Rating(s)
4 Hold Rating(s)
4 Buy Rating(s)
2 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
4 Buy Rating(s)
2 Strong Buy Rating(s)
2 Sell Rating(s)
6 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $79.00$78.22$63.00$67.88
Price Target Upside: 5.86% upside2.26% downside14.57% upside16.11% upside

Davita (NYSE:DVA) Consensus Price Target History

Price Target History for Davita (NYSE:DVA)

Davita (NYSE:DVA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/14/2018SunTrust BanksReiterated RatingHold$80.00MediumView Rating Details
2/13/2018Robert W. BairdSet Price TargetBuy$97.00HighView Rating Details
1/11/2018Bank of AmericaReiterated RatingBuy$85.00 -> $92.00HighView Rating Details
12/11/2017CitigroupUpgradeNeutral -> Buy$67.71 -> $82.00MediumView Rating Details
12/7/2017JPMorgan Chase & Co.Boost Price TargetOutperform -> Strong-Buy$4.90 -> $84.00LowView Rating Details
12/7/2017Raymond James FinancialUpgradeOutperform -> Strong-Buy$65.00 -> $84.00HighView Rating Details
12/6/2017KeyCorpReiterated RatingHoldLowView Rating Details
11/8/2017Royal Bank of CanadaLower Price TargetSector Perform$64.00 -> $60.00N/AView Rating Details
10/23/2017Wolfe ResearchUpgradeMarket Perform -> OutperformN/AView Rating Details
8/3/2017Jefferies GroupReiterated RatingHold$70.00MediumView Rating Details
5/25/2017Goldman Sachs GroupReiterated RatingSell$62.00HighView Rating Details
11/1/2016Wells Fargo & CoReiterated RatingOutperformN/AView Rating Details
4/6/2016Susquehanna BancsharesBoost Price TargetNeutral$70.00 -> $78.00N/AView Rating Details
3/2/2016Sanford C. BernsteinLower Price TargetMarket Perform$74.50 -> $71.00N/AView Rating Details
(Data available from 2/24/2016 forward)

Earnings

Davita (NYSE:DVA) Earnings History and Estimates Chart

Earnings by Quarter for Davita (NYSE:DVA)

Davita (NYSE DVA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/30/2018$0.93N/AView Earnings Details
2/13/2018Q4 2017$0.94$0.92$3.90 billion$2.78 billionViewListenView Earnings Details
11/7/2017Q3 2017$0.94$0.81$3.91 billion$3.92 billionViewN/AView Earnings Details
8/1/2017Q2 2017$0.90$0.92$3.82 billion$3.88 billionViewListenView Earnings Details
5/2/2017Q1 2017$0.82$0.79$3.69 billion$3.70 billionViewListenView Earnings Details
2/16/2017Q4 2016$0.91$0.98$3.74 billion$3.72 billionViewListenView Earnings Details
11/2/2016Q316$0.94$0.95$3.72 billion$3.73 billionViewListenView Earnings Details
8/8/2016Q216$0.98$1.01$3.67 billion$3.72 billionViewListenView Earnings Details
5/4/2016Q116$0.86$0.92$3.51 billion$3.58 billionViewListenView Earnings Details
2/11/2016Q415$0.97$1.01$3.50 billion$3.53 billionViewListenView Earnings Details
11/3/2015Q315$0.97$1.00$3.46 billion$3.53 billionViewListenView Earnings Details
8/4/2015Q215$0.95$0.95$3.37 billion$3.43 billionViewListenView Earnings Details
5/4/2015Q115$0.86$0.86$3.25 billion$3.29 billionViewListenView Earnings Details
2/12/2015Q414$0.89$0.96$3.26 billion$3.33 billionViewListenView Earnings Details
11/6/2014Q314$0.91$0.90$3.19 billion$3.25 billionViewListenView Earnings Details
7/31/2014Q214$0.88$0.95$3.10 billion$3.17 billionViewListenView Earnings Details
5/1/2014Q1$0.87$0.85$3.02 billion$3.04 billionViewListenView Earnings Details
2/11/2014Q413$1.91$0.99$2.92 billion$3.06 billionViewListenView Earnings Details
11/5/2013Q313$0.96$0.98$2.93 billion$3.00 billionViewListenView Earnings Details
8/6/2013Q2 2013$1.84$1.84$2.88 billion$2.87 billionViewListenView Earnings Details
5/7/2013Q1 2013$1.80$1.84$2.78 billion$2.83 billionViewListenView Earnings Details
2/14/2013Q4 2012$1.60$1.85$2.40 billion$2.48 billionViewListenView Earnings Details
10/30/2012$1.55$1.56ViewN/AView Earnings Details
8/1/2012$1.47$1.49ViewN/AView Earnings Details
5/1/2012Q1 2012$0.73$0.73ViewN/AView Earnings Details
2/16/2012$1.49$1.58ViewN/AView Earnings Details
11/3/2011$1.46$1.45ViewN/AView Earnings Details
8/3/2011$1.14$1.17ViewN/AView Earnings Details
5/2/2011$0.95$0.96ViewN/AView Earnings Details
2/10/2011$1.12$0.70ViewN/AView Earnings Details
11/4/2010Q3 2010$0.57$0.57ViewN/AView Earnings Details
8/2/2010Q2 2010$0.54$0.53ViewN/AView Earnings Details
4/27/2010Q1 2010$0.52$0.52ViewN/AView Earnings Details
2/10/2010Q4 2009$0.53$0.53ViewN/AView Earnings Details
11/3/2009Q3 2009$0.50$0.53ViewN/AView Earnings Details
8/4/2009Q2 2009$0.48$0.51ViewN/AView Earnings Details
4/27/2009Q1 2009$0.45$0.46ViewN/AView Earnings Details
2/10/2009Q4 2008$0.45$0.47ViewN/AView Earnings Details
11/3/2008Q3 2008$0.44$0.44ViewN/AView Earnings Details
8/4/2008Q2 2008$0.42$0.45ViewN/AView Earnings Details
4/29/2008Q1 2008$0.39$0.40ViewN/AView Earnings Details
2/13/2008Q4 2007$0.40$0.40ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Davita (NYSE:DVA) Earnings Estimates

2018 EPS Consensus Estimate: $4.00
2019 EPS Consensus Estimate: $4.48
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.88$0.93$0.91
Q2 20182$0.95$1.04$1.00
Q3 20182$1.03$1.04$1.04
Q4 20182$1.01$1.12$1.07
Q1 20192$1.00$1.04$1.02
Q2 20192$1.06$1.15$1.11
Q3 20192$1.15$1.17$1.16
Q4 20192$1.16$1.22$1.19
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Davita (NYSE:DVA)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Davita (NYSE DVA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.10%
Institutional Ownership Percentage: 82.88%
Insider Trades by Quarter for Davita (NYSE:DVA)
Institutional Ownership by Quarter for Davita (NYSE:DVA)

Davita (NYSE DVA) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/16/2018James K HilgerInsiderSell3,572$78.95$282,009.4033,649View SEC Filing  
12/11/2017Charles BergInsiderSell7,048$69.24$488,003.525,359View SEC Filing  
12/8/2017Kent J ThiryChairmanSell81,800$68.04$5,565,672.00View SEC Filing  
12/8/2017Leanne M ZumwaltVPSell949$68.19$64,712.3112,423View SEC Filing  
12/7/2017James K HilgerInsiderSell5,608$69.46$389,531.6847,649View SEC Filing  
12/7/2017Javier RodriguezCEOSell22,532$67.48$1,520,459.36210,317View SEC Filing  
5/15/2017Javier RodriguezCEOSell1,294$66.21$85,675.7499,111View SEC Filing  
5/9/2017Charles BergDirectorSell8,414$65.80$553,641.2034,719View SEC Filing  
5/4/2017William L RoperDirectorSell12,994$65.89$856,174.6645,277View SEC Filing  
8/9/2016Michael David StaffieriCOOSell20,262$73.09$1,480,949.5852,279View SEC Filing  
7/11/2016Jeanine Marie JigantiInsiderSell1,291$78.51$101,356.415,716View SEC Filing  
7/1/2016Jeanine Marie JigantiInsiderSell4,620$77.45$357,819.007,590View SEC Filing  
5/25/2016Pamela M ArwayDirectorSell10,824$77.16$835,179.8436,394View SEC Filing  
5/23/2016James K HilgerCFOSell3,416$76.79$262,314.6429,147View SEC Filing  
5/20/2016Kent J ThiryCEOSell32,880$76.99$2,531,431.2039,184View SEC Filing  
5/17/2016Dennis KogodCEOSell17,700$77.35$1,369,095.0018,766View SEC Filing  
5/17/2016Leanne M ZumwaltVPSell538$77.08$41,469.048,585View SEC Filing  
5/16/2016James K HilgerCFOSell3,983$75.59$301,074.9721,130View SEC Filing  
5/16/2016Javier RodriguezCEOSell36,466$75.44$2,750,995.0464,264View SEC Filing  
5/16/2016Michael David StaffieriCOOSell4,934$75.69$373,454.4612,279View SEC Filing  
5/12/2016Roger ValineDirectorSell8,220$76.34$627,514.8018,324View SEC Filing  
5/10/2016Dennis KogodCEOSell40,048$76.25$3,053,660.0092,716View SEC Filing  
5/6/2016John M NehraDirectorSell16,314$75.56$1,232,685.8436,665View SEC Filing  
4/11/2016Javier RodriguezCEOSell89,912$73.51$6,609,431.12317,397View SEC Filing  
3/21/2016Dennis KogodCEOSell13,455$72.12$970,374.6092,716View SEC Filing  
2/29/2016Pamela M ArwayDirectorSell9,026$66.00$595,716.0036,070View SEC Filing  
2/23/2016Leanne M. ZumwaltVPSell14,587$64.25$937,214.75View SEC Filing  
2/16/2016Dennis KogodCEOSell33,290$61.99$2,063,647.10120,816View SEC Filing  
1/13/2016Christopher James SchnarrInsiderBuy5,000$0.68$3,400.00
1/11/2016Christopher James SchnarrInsiderBuy10,000$0.60$6,000.00
12/17/2015Laura MildenbergerinsiderSell1,440$68.14$98,121.608,447View SEC Filing  
9/22/2015Kim M. RiverainsiderSell40,037$75.48$3,021,992.767,438View SEC Filing  
8/17/2015Carol Anthony DavidsonDirectorSell4,038$79.93$322,757.34View SEC Filing  
6/4/2015Robert J MargolisChairmanSell31,400$83.39$2,618,446.00View SEC Filing  
5/28/2015Michael David StaffieriCOOSell9,050$84.07$760,833.50View SEC Filing  
5/19/2015Robert J MargolisChairmanSell15,700$83.22$1,306,554.00View SEC Filing  
5/18/2015James K HilgerCFOSell3,983$82.10$327,004.30View SEC Filing  
5/18/2015Michael David StaffieriCOOSell2,047$82.03$167,915.41View SEC Filing  
5/18/2015Robert J MargolisChairmanSell15,700$82.24$1,291,168.00View SEC Filing  
5/11/2015James K HilgerCFOSell8,267$82.00$677,894.00View SEC Filing  
5/11/2015Jeanine Marie JigantiInsiderSell2,481$81.95$203,317.95View SEC Filing  
5/11/2015John M NehraDirectorSell12,278$81.85$1,004,954.30View SEC Filing  
4/21/2015Robert J MargolisChairmanSell31,400$82.40$2,587,360.00View SEC Filing  
4/7/2015Robert J MargolisChairmanSell15,700$82.15$1,289,755.00View SEC Filing  
4/6/2015Robert J MargolisChairmanSell15,700$81.49$1,279,393.00View SEC Filing  
3/27/2015Robert J MargolisChairmanSell31,400$81.18$2,549,052.00View SEC Filing  
3/12/2015Robert J MargolisChairmanSell107,374$79.24$8,508,315.76View SEC Filing  
2/27/2015Robert J MargolisChairmanSell21,000$74.29$1,560,090.00View SEC Filing  
2/19/2015Robert J MargolisChairmanSell21,000$73.12$1,535,520.00View SEC Filing  
1/30/2015Robert J MargolisChairmanSell31,400$75.48$2,370,072.00View SEC Filing  
1/23/2015Michael David StaffieriCOOSell21,869$76.05$1,663,137.45View SEC Filing  
1/16/2015Robert J MargolisChairmanSell31,400$74.92$2,352,488.00View SEC Filing  
1/8/2015Kim M RiveraInsiderSell1,111$75.10$83,436.10View SEC Filing  
12/30/2014Robert J MargolisChairmanSell31,400$76.09$2,389,226.00View SEC Filing  
12/29/2014Robert J MargolisChairmanSell15,700$76.09$1,194,613.00View SEC Filing  
12/19/2014Laura MildenbergerInsiderSell1,446$75.50$109,173.00View SEC Filing  
12/18/2014Robert J MargolisChairmanSell31,400$74.67$2,344,638.00View SEC Filing  
12/3/2014Robert J MargolisChairmanSell31,400$75.80$2,380,120.00View SEC Filing  
12/1/2014Kim M RiveraInsiderSell6,503$76.08$494,748.24View SEC Filing  
11/21/2014Robert J MargolisChairmanSell31,400$75.08$2,357,512.00View SEC Filing  
11/11/2014Kent J ThiryCEOSell344,938$74.52$25,704,779.76View SEC Filing  
11/11/2014Robert J MargolisChairmanSell250,000$75.09$18,772,500.00View SEC Filing  
11/10/2014Berkshire Hathaway IncMajor ShareholderBuy944,418$74.11$69,990,817.98View SEC Filing  
11/7/2014R. Ted WeschlerMajor ShareholderBuy820,018$74.10$60,763,333.80View SEC Filing  
11/3/2014Roger ValineDirectorSell7,185$77.85$559,352.25View SEC Filing  
9/16/2014John M NehraDirectorSell20,000$73.91$1,478,200.00View SEC Filing  
9/8/2014Kim M RiveraInsiderSell1,111$74.25$82,491.75View SEC Filing  
8/27/2014Leanne M ZumwaltVPSell3,214$74.57$239,667.98View SEC Filing  
8/11/2014Jeanine Marie JigantiInsiderSell2,500$72.14$180,350.00View SEC Filing  
6/11/2014Kim M RiveraInsiderSell5,929$71.05$421,255.45View SEC Filing  
5/29/2014Laura MildenbergerInsiderSell5,080$69.99$355,549.20View SEC Filing  
5/16/2014Dennis KogodCOOSell18,750$67.30$1,261,875.0040,874View SEC Filing  
5/16/2014Kent ThiryCEOSell17,600$67.41$1,186,416.00247,950View SEC Filing  
5/15/2014James HilgerCAOSell1,666$67.23$112,005.1813,277View SEC Filing  
5/15/2014Javier RodriguezCEOSell7,000$67.50$472,500.0064,264View SEC Filing  
5/12/2014Dennis KogodCOOSell32,188$68.06$2,190,715.2859,624View SEC Filing  
5/8/2014Dennis KogodCOOSell32,213$67.36$2,169,867.6859,624View SEC Filing  
5/7/2014Michael David StaffieriCOOSell2,633$67.30$177,200.90View SEC Filing  
4/2/2014Michael David StaffieriCOOSell2,867$69.15$198,253.052,633View SEC Filing  
3/20/2014Laura MildenbergerInsiderSell3,274$70.04$229,310.966,036View SEC Filing  
2/26/2014R. Ted Weschlermajor shareholderBuy1,159,858$66.97$77,675,690.262,191,806View SEC Filing  
2/21/2014John NehraDirectorSell40,000$65.81$2,632,400.0081,766View SEC Filing  
2/18/2014William RoperDirectorSell42,519$66.37$2,821,986.034,994View SEC Filing  
12/20/2013Laura MildenbergerInsiderSell10,417$62.53$651,375.016,036View SEC Filing  
12/17/2013Allen NissensonInsiderSell2,929$59.83$175,242.072,508View SEC Filing  
12/9/2013Berkshire Hathaway Incmajor shareholderBuy1,314,170$57.84$76,011,592.80View SEC Filing  
11/8/2013R. Ted Weschlermajor shareholderBuy3,700,294$55.14$204,034,211.161,095,903View SEC Filing  
7/5/2013Berkshire Hathaway IncMajor ShareholderBuy110,309$114.01$12,576,329.09View SEC Filing  
7/3/2013R. Ted WeschlerMajor ShareholderBuy639,200$114.78$73,367,376.00View SEC Filing  
5/15/2013David T ShapiroInsiderSell8,779$129.80$1,139,514.20View SEC Filing  
5/15/2013Dennis KogodCOOSell21,130$129.47$2,735,701.10View SEC Filing  
5/15/2013James K HilgerCFOSell1,049$130.18$136,558.82View SEC Filing  
5/15/2013Leanne M ZumwaltVPSell13,209$129.59$1,711,754.31View SEC Filing  
5/13/2013Kent J ThiryCEOSell243,307$129.95$31,617,744.65View SEC Filing  
5/13/2013Kim M RiveraInsiderSell1,672$129.70$216,858.40View SEC Filing  
3/4/2013Berkshire Hathaway IncMajor ShareholderBuy164,947$119.59$19,726,011.73View SEC Filing  
3/4/2013Roger ValineDirectorSell1,390$120.00$166,800.00View SEC Filing  
2/27/2013Berkshire Hathaway IncMajor ShareholderBuy211,889$116.56$24,697,781.84View SEC Filing  
2/22/2013Berkshire Hathaway IncMajor ShareholderBuy224,091$115.88$25,967,665.08View SEC Filing  
2/19/2013Berkshire Hathaway IncMajor ShareholderBuy323,070$116.73$37,711,961.10View SEC Filing  
2/5/2013Berkshire Hathaway IncMajor ShareholderBuy32,376$115.17$3,728,743.92View SEC Filing  
2/4/2013Roger ValineDirectorSell1,389$116.13$161,304.57View SEC Filing  
1/16/2013Berkshire Hathaway IncMajor ShareholderBuy42,400$111.33$4,720,392.00View SEC Filing  
1/15/2013Berkshire Hathaway IncMajor ShareholderBuy179,300$109.67$19,663,831.00View SEC Filing  
1/10/2013Berkshire Hathaway IncMajor ShareholderBuy187,898$109.54$20,582,346.92View SEC Filing  
12/24/2012Dennis KogodCOOSell12,736$111.00$1,413,696.00View SEC Filing  
12/21/2012James K HilgerCFOSell2,073$112.20$232,590.60View SEC Filing  
12/6/2012Berkshire Hathaway IncMajor ShareholderBuy635,633$106.20$67,504,224.60View SEC Filing  
11/29/2012Berkshire Hathaway IncMajor ShareholderBuy679,249$108.20$73,494,741.80View SEC Filing  
11/26/2012Berkshire Hathaway IncMajor ShareholderBuy412,050$110.38$45,482,079.00View SEC Filing  
11/16/2012Berkshire Hathaway IncMajor ShareholderBuy132,958$112.45$14,951,127.10View SEC Filing  
11/12/2012Berkshire Hathaway IncMajor ShareholderBuy548,823$112.15$61,550,499.45View SEC Filing  
11/7/2012Berkshire Hathaway IncMajor ShareholderBuy139,491$112.03$15,627,176.73View SEC Filing  
11/2/2012Berkshire Hathaway IncMajor ShareholderBuy254,750$112.20$28,582,950.00View SEC Filing  
10/26/2012Berkshire Hathaway IncMajor ShareholderBuy257,941$111.14$28,667,562.74View SEC Filing  
10/17/2012Berkshire Hathaway IncMajor ShareholderBuy63,928$109.56$7,003,951.68View SEC Filing  
10/12/2012Berkshire Hathaway IncMajor ShareholderBuy217,597$109.76$23,883,446.72View SEC Filing  
10/9/2012Berkshire Hathaway IncMajor ShareholderBuy67,946$107.71$7,318,463.66View SEC Filing  
9/28/2012Berkshire Hathaway IncMajor ShareholderBuy282,403$102.03$28,813,578.09View SEC Filing  
8/8/2012Kent J ThiryChairmanSell320,877$96.88$31,086,563.76View SEC Filing  
8/7/2012William L RoperDirectorSell23,019$95.95$2,208,673.05View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Davita (NYSE DVA) News Headlines

Source:
DateHeadline
Norinchukin Bank The Sells 15,931 Shares of Davita Inc (DVA)Norinchukin Bank The Sells 15,931 Shares of Davita Inc (DVA)
www.americanbankingnews.com - February 24 at 2:18 PM
BlackRock Inc. Acquires 3,120 Shares of Davita Inc (DVA)BlackRock Inc. Acquires 3,120 Shares of Davita Inc (DVA)
www.americanbankingnews.com - February 24 at 10:18 AM
Married 5 Times, But Theres Hope: DaVita Earnings Update - Seeking Alpha'Married 5 Times,' But There's Hope: DaVita Earnings Update - Seeking Alpha
seekingalpha.com - February 24 at 8:11 AM
Davita Inc (DVA) Shares Sold by Sei Investments Co.Davita Inc (DVA) Shares Sold by Sei Investments Co.
www.americanbankingnews.com - February 24 at 5:40 AM
DaVita Inc (DVA) Files 10-K for the Fiscal Year Ended on December 31, 2017DaVita Inc (DVA) Files 10-K for the Fiscal Year Ended on December 31, 2017
finance.yahoo.com - February 23 at 6:02 PM
Equities Analysts Offer Predictions for Davita Incs FY2020 Earnings (DVA)Equities Analysts Offer Predictions for Davita Inc's FY2020 Earnings (DVA)
www.americanbankingnews.com - February 23 at 4:54 PM
Davita Inc (DVA) Given Consensus Rating of "Hold" by AnalystsDavita Inc (DVA) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - February 21 at 1:46 AM
Research Report Identifies BofI Holding, TrueBlue, Essendant, DaVita HealthCare Partners, The Travelers Companies, and Huntsman with Renewed Outlook — Fundamental Analysis, Calculating Forward MovementResearch Report Identifies BofI Holding, TrueBlue, Essendant, DaVita HealthCare Partners, The Travelers Companies, and Huntsman with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
finance.yahoo.com - February 20 at 8:14 AM
Analysts Set Expectations for Davita Incs Q1 2018 Earnings (DVA)Analysts Set Expectations for Davita Inc's Q1 2018 Earnings (DVA)
www.americanbankingnews.com - February 16 at 8:38 AM
Davita Inc Forecasted to Earn Q1 2018 Earnings of $0.88 Per Share (DVA)Davita Inc Forecasted to Earn Q1 2018 Earnings of $0.88 Per Share (DVA)
www.americanbankingnews.com - February 16 at 8:38 AM
DaVita (DVA) Beats Q4 Earnings Estimates, Misses Revenues - NasdaqDaVita (DVA) Beats Q4 Earnings Estimates, Misses Revenues - Nasdaq
www.nasdaq.com - February 16 at 8:14 AM
Davita Inc to Post FY2019 Earnings of $4.43 Per Share, William Blair Forecasts (DVA)Davita Inc to Post FY2019 Earnings of $4.43 Per Share, William Blair Forecasts (DVA)
www.americanbankingnews.com - February 15 at 3:10 PM
Davita (DVA) Rating Reiterated by SunTrust BanksDavita (DVA) Rating Reiterated by SunTrust Banks
www.americanbankingnews.com - February 14 at 4:54 PM
Robert W. Baird Analysts Give Davita (DVA) a $97.00 Price TargetRobert W. Baird Analysts Give Davita (DVA) a $97.00 Price Target
www.americanbankingnews.com - February 14 at 1:38 PM
DaVita (DVA) Misses Q4 EPS by 9c, Miss on RevenuesDaVita (DVA) Misses Q4 EPS by 9c, Miss on Revenues
www.streetinsider.com - February 14 at 9:27 AM
DaVita HealthCare tops 4Q profit forecastsDaVita HealthCare tops 4Q profit forecasts
finance.yahoo.com - February 14 at 9:27 AM
DaVita Kidney Care Encourages Americans to Become Organ DonorsDaVita Kidney Care Encourages Americans to Become Organ Donors
finance.yahoo.com - February 14 at 9:27 AM
DaVita eyes acquisitions, share buy-backs with cash windfallDaVita eyes acquisitions, share buy-backs with cash windfall
finance.yahoo.com - February 14 at 9:27 AM
DaVita Inc. (DVA) Q4 2017 Earnings Conference Call TranscriptDaVita Inc. (DVA) Q4 2017 Earnings Conference Call Transcript
www.fool.com - February 14 at 1:43 AM
Davita (DVA) Announces Quarterly  Earnings Results, Meets ExpectationsDavita (DVA) Announces Quarterly Earnings Results, Meets Expectations
www.americanbankingnews.com - February 13 at 7:08 PM
Davita (DVA) Rating Lowered to Hold at Zacks Investment ResearchDavita (DVA) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - February 13 at 5:54 PM
DaVita Earnings PreviewDaVita Earnings Preview
finance.yahoo.com - February 13 at 3:41 PM
Davita (DVA) Raised to "Buy" at Zacks Investment ResearchDavita (DVA) Raised to "Buy" at Zacks Investment Research
www.americanbankingnews.com - February 6 at 7:24 PM
DaVita (DVA) to Report Q4 Earnings: Whats in the Cards?DaVita (DVA) to Report Q4 Earnings: What's in the Cards?
finance.yahoo.com - February 6 at 3:40 PM
The Evolution of My Research Process - Part IThe Evolution of My Research Process - Part I
finance.yahoo.com - February 6 at 3:40 PM
DaVita (DVA) to Report Q4 Earnings: What's in the Cards?DaVita (DVA) to Report Q4 Earnings: What's in the Cards?
finance.yahoo.com - February 6 at 3:40 PM
Davita (DVA) to Release Earnings on TuesdayDavita (DVA) to Release Earnings on Tuesday
www.americanbankingnews.com - February 6 at 3:44 AM
Government Report Reveals Dialysis Industry Improves Patient CareGovernment Report Reveals Dialysis Industry Improves Patient Care
finance.yahoo.com - February 5 at 9:16 AM
Davita promotes Dr. Aric Coffman to CEO and market president of ... - Albuquerque Business FirstDavita promotes Dr. Aric Coffman to CEO and market president of ... - Albuquerque Business First
www.bizjournals.com - February 2 at 9:02 AM
DaVita Inc. Schedules 4th Quarter 2017 Investor Conference CallDaVita Inc. Schedules 4th Quarter 2017 Investor Conference Call
finance.yahoo.com - February 1 at 9:16 AM
First Week of DVA March 16th Options TradingFirst Week of DVA March 16th Options Trading
www.nasdaq.com - January 31 at 3:40 PM
The Everett Clinic Announces Senior Leadership TransitionsThe Everett Clinic Announces Senior Leadership Transitions
finance.yahoo.com - January 31 at 3:40 PM
Davita Inc (DVA) Given Average Rating of "Hold" by BrokeragesDavita Inc (DVA) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - January 27 at 2:04 AM
Kindred Healthcare (KND) versus Davita (DVA) Head-To-Head ContrastKindred Healthcare (KND) versus Davita (DVA) Head-To-Head Contrast
www.americanbankingnews.com - January 25 at 1:06 AM
With 3 female board members, DaVita makes new gender equality listWith 3 female board members, DaVita makes new 'gender equality' list
www.bizjournals.com - January 24 at 3:48 PM
DaVita Named Inaugural Member of Bloomberg Gender-Equality Index 2018 - PR Newswire (press release)DaVita Named Inaugural Member of Bloomberg Gender-Equality Index 2018 - PR Newswire (press release)
www.prnewswire.com - January 24 at 8:02 AM
DaVita Recognized as a Top Green Company by NewsweekDaVita Recognized as a Top Green Company by Newsweek
finance.yahoo.com - January 23 at 5:29 PM
DaVita Named Inaugural Member of Bloomberg Gender-Equality Index 2018DaVita Named Inaugural Member of Bloomberg Gender-Equality Index 2018
finance.yahoo.com - January 22 at 3:50 PM
 Analysts Expect Davita Inc (DVA) Will Post Quarterly Sales of $3.89 Billion Analysts Expect Davita Inc (DVA) Will Post Quarterly Sales of $3.89 Billion
www.americanbankingnews.com - January 20 at 9:08 AM
Davita Sees Unusually Large Options Volume (DVA)Davita Sees Unusually Large Options Volume (DVA)
www.americanbankingnews.com - January 20 at 3:10 AM
Insider Selling: Davita Inc (DVA) Insider Sells 3,572 Shares of StockInsider Selling: Davita Inc (DVA) Insider Sells 3,572 Shares of Stock
www.americanbankingnews.com - January 18 at 9:28 PM
[$$] UnitedHealth Says Tax Overhaul To Boost 2018 Earnings[$$] UnitedHealth Says Tax Overhaul To Boost 2018 Earnings
finance.yahoo.com - January 17 at 9:34 AM
UnitedHealths Optum Now In Half Of 75 Targeted Provider MarketsUnitedHealth's Optum Now In Half Of 75 Targeted Provider Markets
finance.yahoo.com - January 17 at 9:34 AM
[$$] UnitedHealth Profit Rises as Both Healthcare, Optum Businesses Grow[$$] UnitedHealth Profit Rises as Both Healthcare, Optum Businesses Grow
finance.yahoo.com - January 16 at 9:44 AM
DaVita (DVA) Partners with Epic to Launch EHR for PatientsDaVita (DVA) Partners with Epic to Launch EHR for Patients
finance.yahoo.com - January 15 at 5:09 PM
Investors Purchase Large Volume of Put Options on Davita (DVA)Investors Purchase Large Volume of Put Options on Davita (DVA)
www.americanbankingnews.com - January 15 at 3:40 AM
Robert W. Baird Reiterates "Buy" Rating for Davita (DVA)Robert W. Baird Reiterates "Buy" Rating for Davita (DVA)
www.americanbankingnews.com - January 14 at 3:34 PM
DaVita Physician Solutions Makes Its First Big Investment in New Technology from EpicDaVita Physician Solutions Makes Its First Big Investment in New Technology from Epic
finance.yahoo.com - January 11 at 5:15 PM
Davita (DVA) Stock Rating Reaffirmed by Bank of AmericaDavita (DVA) Stock Rating Reaffirmed by Bank of America
www.americanbankingnews.com - January 11 at 9:40 AM
DaVita Inc. to Present at the 36th Annual J.P. Morgan Healthcare ConferenceDaVita Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 10 at 9:46 AM

SEC Filings

Davita (NYSE:DVA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Davita (NYSE:DVA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Davita (NYSE DVA) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.